IGF2BP3 and bladder transitional cell carcinoma: Through identification of the characteristics of the expression of the three hub regulators of the m6A modification (FTO, IGF2BP3, and YTHDC1) and using the consensus clustering analysis, BLCA samples in the TCGA database were divided into two subgroups.